Relay Therapeutics, Inc.

US$18.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RLAYHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (9.78%)
Div yield —
ROE (41.16%)
Biotechnology
Beta (5Y) 1.74
PE TTM —
TSR TTM 160.50%
Mkt cap US$4.110B
ROIC (26.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$24
27.60%
(61.94%)
Hold 2|9|5|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.23
0.23
0.24
0.26
27.68%
26.77%
21.69%
23.31%
Revenue$M
297.3
302.0
315.1
319.2
17.62%
12.86%
14.32%
10.35%
Peers (US$4.110B)
Cap (US$)
PE
4.534B
—
4.058B
—
Capital
TTM
5Y
10Y
Leveragex
1.483
0.403
0.330
EBIT/Intx
0.216
0.176
0.147
Own earn%
222.32
55.62
65.44
Sh yield%
38.28
49.58
49.69
Owners
Insiders/Inst%
6.15
47.53
Short interest%
5.28
SBC / revenue%
4.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
22–26
$1 testx
—
Incr. ROIC%
13